AorTech buys Australian polymer partner for $20 million
This article was originally published in Clinica
Executive Summary
AorTech International, a UK mechanical heart valve company that is developing the Trileaflet synthetic valve, has bought the company that makes the device's polymer coating. Aortech is paying approximately £20 million ($31 million) for the 67% that it did not own in Elastomedic, an Australian materials technology company.